XML 47 R33.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Segment Reporting (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information, by Segment | Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three and nine-month periods ended September 30, 2022 and 2021, were as follows (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended |  | Nine Months Ended
​ |  | September 30, |  | September 30,
​ |  | 2022 |  | 2021 |  | 2022 |  | 2021
Net sales |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Cardiovascular | ​ | $ | 278,949 | ​ | $ | 259,704 | ​ | $ | 832,555 | ​ | $ | 773,002
Endoscopy | ​ |  | 8,226 | ​ |  | 7,317 | ​ |  | 25,011 | ​ |  | 23,257
Total net sales | ​ |  | 287,175 | ​ |  | 267,021 | ​ |  | 857,566 | ​ |  | 796,259
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income from operations | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Cardiovascular | ​ |  | 17,435 | ​ |  | 14,411 | ​ |  | 51,836 | ​ |  | 33,389
Endoscopy | ​ |  | 1,222 | ​ |  | 1,520 | ​ |  | 5,310 | ​ |  | 5,631
Total income from operations | ​ |  | 18,657 | ​ |  | 15,931 | ​ |  | 57,146 | ​ |  | 39,020
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total other expense — net | ​ |  | (1,055) | ​ |  | (1,754) | ​ |  | (4,672) | ​ |  | (5,284)
Income tax expense | ​ |  | 2,330 | ​ |  | 2,210 | ​ |  | 11,359 | ​ |  | 5,895
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net income | ​ | $ | 15,272 | ​ | $ | 11,967 | ​ | $ | 41,115 | ​ | $ | 27,841

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration